Dr. Agarwal's Health Care Ltd. (AGARWALEYE) fundamentals
Dr. Agarwal's Health Care Ltd. is a listed company in Healthcare Services, part of the Healthcare sector, listed on the NSE as AGARWALEYE (ISIN INE943P01029). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Dr. Agarwal's Health Care Ltd. does
Dr. Agarwal's Health Care Ltd is an India-based company, which operates as a health care institution. The Company is engaged in running, owning and managing eye care hospitals, optical, pharmacies, etc. and related services. It provides a comprehensive range of eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sells optical, contact lenses and accessories, and eye-care related pharmaceutical products. Its services include surgeries and consultations, diagnoses and non-surgical treatments. Its surgery services include cataract surgery, refractive surgery, and other surgery. Its consultations, diagnoses and non-surgical treatments offer doctor consultation services, diagnostic services for eye disorders along with non-surgical treatments, including retinal laser therapy and dry eye treatment. It provides a range of glasses, lenses, contact lenses and frames at its facilities.
Valuation and market data
| Last close | ₹475.00 |
|---|---|
| Market capitalisation | ₹18,971 crore |
| Enterprise value | ₹20,241 crore |
| P/E (TTM) | 112.83 |
| Price to book | 8.95 |
| Price to sales (TTM) | 5.06 |
| Book value per share | ₹53.07 |
| Dividend yield | 0.00% |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Listed since | Tue Feb 04 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹2,125 crore | ₹249 crore | ₹168 crore | 4.21 |
| Mar 2025 | ₹1,757 crore | ₹160 crore | ₹110 crore | 2.80 |
| Mar 2024 | ₹1,376 crore | ₹141 crore | ₹95 crore | 3.14 |
| Mar 2023 | ₹1,031 crore | ₹84 crore | ₹103 crore | 4.01 |
| Mar 2022 | ₹714 crore | ₹57 crore | ₹43 crore | 1.83 |
Figures are as reported (consolidated), in ₹ crore.
Shareholding pattern
As of Sep 2026:
| Promoters | 32.3% |
|---|---|
| Foreign institutions (FII) | 49.6% |
| Mutual funds | 14.2% |
| Other domestic institutions | 1.7% |
| Retail and others | 2.2% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.